methamphetamine has been researched along with kynurenine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carrico, AW; Chahine, A; Cohn, M; Dilworth, SE; Fuchs, D; Gouse, H; Lee, J; Lee, JY; Magidson, JF; Meade, CS | 1 |
| Budzynska, B; Kaszubska, K; Kotlinska, JH; Lemieszek, MK; Marciniak, S; Marszalek-Grabska, M; Rzeski, W; Turski, WA; Winiarczyk, S; Zakrocka, I | 1 |
2 other study(ies) available for methamphetamine and kynurenine
| Article | Year |
|---|---|
Tryptophan degradation is associated with risk-taking propensity in methamphetamine users with treated HIV infection.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Biotransformation; Cross-Sectional Studies; HIV Infections; Homosexuality, Male; Humans; Impulsive Behavior; Kynurenine; Male; Methamphetamine; Middle Aged; Phenylalanine; Psychological Tests; Risk-Taking; Substance-Related Disorders; Tryptophan; Tyrosine; Viral Load | 2020 |
Binge-like mephedrone treatment induces memory impairment concomitant with brain kynurenic acid reduction in mice.
Topics: Adolescent; Animals; Humans; Kynurenic Acid; Kynurenine; Methamphetamine; Mice; Transaminases; Tryptophan | 2022 |